Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 544Triple Negative Breast Neoplasms 87Neoplasms 19Colorectal Neoplasms 19Lung Neoplasms 16Advanced Breast Cancer 16Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Motor Activity 12Breast Cancer Lymphedema 12HER2-positive Breast Cancer 11Uterine Cervical Neoplasms 10Stomach Neoplasms 10Ovarian Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Anxiety Disorders 10Endometrial Neoplasms 9Depression 8Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Pain, Postoperative 6Pain 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Cardiotoxicity 6Sarcoma 5Pancreatic Neoplasms 5

Interventions

pyrotinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Metastatic Breast Cancer in the Brain × Breast × Clear all
NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

Henan Cancer Hospital

Phase 2 Not yet recruiting
32 enrolled
Breast

Metastatic Breast Cancer in the Brain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡